← Leaderboards
Urvi M. Parikh
University Of California, San Francisco
$1,674,974
Attributed
$3,799,549
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,799,549 · 3
By mechanism
R01$3,134,333 · 1
R44$545,966 · 1
UM1$119,250 · 1
Top collaborators
- Catherine Anne Stimets Koss4 shared
- Catherine Chappell1 shared
- Beatrice A. Chen1 shared
- Ann E. Jerse1 shared
- Susan L Koletar1 shared
- John W Mellors1 shared
- Barbara Best North1 shared
- Gail S Prins1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Monica Gandhi$27,077,063
- Elizabeth Anne Bukusi$10,479,882
- Sheri Dawn Weiser$14,342,815
- Catherine Anne Stimets Koss$3,514,120
- Diane V Havlir$125,216,731
Others in their field
Other Rising Stars on “Aids Prevention”
- Shaunna Shen · Duke University$7,747,008
- Tamara Taggart · George Washington University$5,211,993
- Dhiraj Kumar Singh · Texas Biomedical Research Institute$3,900,756
- Schenita D. Randolph · Duke University$3,870,187
- Mary D Shaw · Jackson State University$3,716,002
- Lashonda Spencer · University Of California Los Angeles$3,647,613
Research focus
Aids PreventionPharmaceutical PreparationsParticipantSamplingDrug KineticsEpidemicPre-Exposure ProphylaxisPlasmaPreventionServicesResearch PersonnelAdherenceEnrollmentAnti-Retroviral AgentsLaboratoriesModalityFutureDrug ResistanceHiv InfectionsAcute InfectionBehavioralDiagnosisBehaviorAfrica South Of The Sahara
Grant awards (6)
ACTION: Study of ACuTe Infections On Novel HIV Prevention Modalities$772,120
R01 · FY2025 · AI
First in Human Clinical Trial of a Contraceptive MPT YASO GEL$545,966
R44 · FY2025 · HD
Pitt-Ohio State Clinical Trials Unit$119,250
UM1 · FY2025 · AI
ACTION: Study of ACuTe Infections On Novel HIV Prevention Modalities$772,120
R01 · FY2024 · AI
ACTION: Study of ACuTe Infections On Novel HIV Prevention Modalities$777,152
R01 · FY2023 · AI
ACTION: Study of ACuTe Infections On Novel HIV Prevention Modalities$812,941
R01 · FY2022 · AI